We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota. Organised in collaboration with the ISA Board and members of Mayo Clinic, the program promises to be both informative and engaging.

The symposium will feature a comprehensive scientific program covering various types of systemic amyloidosis, including ATTR (hereditary and wild-type), AL (light-chain), AA, and less frequent forms.

The program will delve into the basic science, pathophysiology, diagnosis, and current and emerging treatments of systemic amyloidosis. Participants will have the opportunity to learn from competitive oral and poster abstracts, gaining insights into the latest advancements in the field.

We encourage you to join Dr. Taubel and other experts in the field for what promises to be an enlightening and educational experience. 

To find out more: https://cveducation.mayo.edu/store/international-symposium-on-amyloidosis 

Latest news

Richmond Pharmacology Appoints Patrick Ramiah as Director of Clinical Project Delivery & Operational Excellence

September 1, 2025
Richmond Pharmacology is delighted to announce the promotion of Patrick Ramiah to the role of Director of Clinical Project Delivery & Operational Excellence, effective from 1 September 2025.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event